Impeto Medical About Us

Impeto Medical devices: EZSCAN and SUDOSCAN



Impeto Medical

Our CEO, Philippe Brunswick, presents Impeto Medical on Worldwide Business with Kathy Ireland

Activation of the sweat glands to detect small fiber nerves neuropathy


Newscast: Impeto Medical News


2017 Events Calendar

2017 Events Calendar Diabetes French Society for Diabetes (Société Francophone du Diabète, SFD) - More here  March 28-31, 2017 - Lille, France ...
Read More

Impeto Medical will be at the 2017 ADA in San Diego

Impeto Medical will be present at the 2017 ADA in San Diego, on booth #2115 This year, the ADA in ...
Read More

Impeto Medical in french newspaper Le Monde

On April 28th, 2017, the french newspaper « Le Monde » published in their section Broad Angle, an « Innovations in health » special ...
Read More

> Our Mission

Impeto Medical is a privately owned medical device company formed in June 2005. Its corporate headquarters are located in Paris, France. Two subsidiaries have been created: Beijing Impeto Medical in China and Impeto Medical Inc. in San Diego, U.S.

Our goal is to provide the medical community with screening tests to face epidemically spreading metabolic disorders and their complications. By providing less invasive, faster and less costly procedures, we enable physicians to screen larger patient populations and to detect diseases and complications earlier. We build value for our investors through constant innovation based on clinical research as well as focus on priority medical issues.

> Patents

The SUDOCAN® device is covered by following patents : "Electrophysiological analysis system and method" (Patent 1 898 783 and 2 124 736), and "Procédé d'analyse physiologique par stabilisation d'une surtension" (PCT2014/069479).